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Abstract 29 
Objectives: Examine if exercise referral schemes (ERSs) are associated with meaningful 30 
changes in physical activity (PA) in a large cohort of individuals throughout England, 31 
Scotland and Wales from The National Referral Database. 32 
Methods: Data were obtained from 5,246 participants from 12 different ERSs lasting 12 33 
weeks. Pre-exercise referral scheme, and changes from pre- to post-exercise referral scheme 34 
in self-reported International Physical Activity Questionnaire scores were examined. Two-35 
stage individual patient data meta-analysis was used to generate effect estimates. 36 
Results: For pre-ERS MET-minutes/week the estimate [95% CI] was 676 MET-37 
minutes/week [539, 812 minutes]. For change in MET-minutes/week the estimate [95% CI] 38 
was an increase of 540 MET-minutes/week [396, 684]. Changes in total PA levels occurred 39 
as a result of increases in vigorous activity of 17 minutes [95% CI 9, 24], increases in 40 
moderate activity of 29 minutes [95% CI 22, 36], and reductions in sitting of -61 minutes 41 
[95% CI -78, -43], though little change in walking (-5 minutes [95% CI -14, 5]).  42 
Conclusions: Most participants undergoing ERSs are already ‘moderately active’. Changes 43 
in PA behaviour associated with participation are through increased moderate-to-vigorous PA 44 
and reduced sitting. However, this was insufficient to change IPAQ category and participants 45 
where still ‘moderately active’.  46 
 47 
 48 
 49 
 50 
 51 
 52 
 53 
 54 
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What is already known on this topic? 55 
 Physical activity is widely considered to be effective in the prevention, management, and 56 
treatment of many chronic health disorders, yet population physical activity levels are 57 
relatively low and have changed little in recent years. 58 
 Sufficient physical activity levels for health and wellbeing often do not arise as result of 59 
typical activities of daily living and thus, specific exercise has been argued to be necessary for 60 
many, and one approach to providing this has been through exercise referral schemes.  61 
 Exercise referral schemes are aimed at increasing physical activity levels in sedentary 62 
individuals with chronic disease, however, despite evidence of the benefits of physical 63 
activity, the evidence base regarding whether these are an effective approach to increase 64 
physical activity is currently limited. 65 
 66 
What this study adds 67 
 Our findings suggest that, exercise referral schemes may not be targeting the population for 68 
which they are aimed as participants are typically classified as ‘moderately active’ prior to 69 
beginning their exercise referral scheme, or that participants are overestimating their levels of 70 
physical activity. 71 
 Exercise referral schemes are associated with a statistically significant change in total 72 
physical activity with most of this accounted for by increases in moderate-vigorous physical 73 
activity (increasing 17 minutes and 29 minutes per week respectively), in addition to 74 
reductions in sitting time (reducing by 61 minutes per week); however, the size of the changes 75 
was not sufficient for participants to move from the ‘moderately active’ category to ‘highly 76 
active’ category.  77 
 These findings suggest the need to consider exercise referral schemes and their 78 
implementation more critically. It would seem that they may not be targeting those who are 79 
most inactive, or that participants are overestimating their physical activity levels at baseline, 80 
and this may perhaps explain why changes were not sufficient to change activity category.  81 
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Introduction 82 
 Physical activity (PA) is widely considered an effective prevention and management tool for 83 
a wide range of chronic health disorders.
1-3
 PA is considered as any bodily movement created by 84 
skeletal muscles that results in greater demand of energy expenditure than would normally be 85 
required.
4
 PA can be conducted in many ways, including unstructured activities as part of an 86 
individual’s daily living, leisure activities, or occupation, and is often performed without the explicitly 87 
desired goal of improving fitness. Improving health and fitness can be a by-product of these 88 
unstructured activities, although unstructured physical activity is decreasing within the modern era.
5
 89 
 Worldwide, one in four adults do not meet the current global recommendations for PA, which 90 
suggest that adults should undertake 150 minutes of moderate-intensity activity per week.
4 91 
Approximately 20 million adults in the UK are not physically active,
6 
a figure that has remained 92 
relatively unchanged in the recent years.
7 
Physical inactivity is a public health dilemma in that it is 93 
associated with increased risk of non-communicable diseases (NCDs) including obesity, 94 
cardiovascular diseases, diabetes, and premature death.
7 
Physical inactivity has reportedly increased 95 
globally, having serious consequences on health and wellbeing.
7-9 
In contrast to inactivity which is 96 
associated with a range of negative health outcomes, physical activity is associated with a range of 97 
positive health outcomes.
2,5 
Indeed, network meta-analyses have shown PA interventions, including 98 
structured bouts of PA (i.e. exercise), are similarly, and in some cases, more effective than drug 99 
treatments for secondary prevention.
10,11
 100 
 Considering this, interventions to increase PA in primary care might present a solution to 101 
reduce the heavy burden that inactivity related NCDs place upon the National Health Service 102 
(NHS),
12 
which at present has risen to £1.2 billion per year.
7
 Exercise referral schemes (ERSs) are 103 
exercise interventions aimed at increasing the number of sedentary individuals becoming active, along 104 
with aiding the rehabilitation and management of chronic health disorders.
1,13,14  
Schemes were first 105 
introduced in the 1990s in primary care settings across England to facilitate PA participation for 106 
individuals referred with chronic health disorders.
15 
Professionals in primary care (usually 107 
physicians/general practitioners (GPs), but also nurses, physiotherapists and condition-specific 108 
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specialists) typically refer individuals to third party service providers, usually in leisure centres and 109 
gyms, who then prescribe an exercise programme and monitor progress accordingly.  110 
 Guidance for ERSs in England, published by The National Institute for Health and Care 111 
Excellence (NICE), ‘PH54: Physical Activity: Exercise Referral Schemes’,13 are vague in the details 112 
regarding what exercise providers should base their schemes upon. However, they do suggest that 113 
schemes should typically consist of a 12 weeks’ exercise prescription and should target inactive 114 
individuals with chronic health disorders. Yet, the evidence available for inactive but presently 115 
healthy individuals specifically, was considered weak at the time of the 2014 guidelines, which in 116 
recent consultation have remained the same.
16 
The NICE guidelines do not provide any details of the 117 
specific exercise prescriptions used within schemes. In addition, ERSs have been described as ‘wild 118 
and woolly’, with a lack of agreement between stakeholders on how to determine impact.17 Although 119 
increasing PA levels, both during the intervention and resultant from it, is a primary aim of ERSs, 120 
there has been little research documenting change in PA levels after scheme completion; and what has 121 
been conducted appears conflicting.
1,18-20
 This is of particular relevance as recent observational 122 
findings reported from ERSs in The National Referral Database, suggest that changes in health and 123 
wellbeing outcomes may not reach meaningful levels.
21 
It is important to provide an update of 124 
evidence of whether ERSs do impact PA across England, Scotland and Wales, to meet the 125 
recommendations from NICE, and in order to understand whether a possible explanation for the lack 126 
of health and wellbeing outcomes may be due to insufficient changes in PA levels. Documenting 127 
change in PA levels was also a recommendation for further research from NICE.
13
 The aim of this 128 
study was therefore to examine whether ERSs are effective in providing change in PA in participants 129 
who had completed an ERS, using observational data from The National Referral Database, to meet 130 
recommendations for further research from NICE, and to review data from the first national database 131 
in the United Kingdom (UK). 132 
 133 
Methods 134 
Study Design 135 
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 Anonymised data were extracted from the The National Referral Database uploaded from 136 
ERSs across England, Wales and Scotland. Referrals from primary care to ERSs were made between 137 
September 2011 and October 2017. At the time of the data cut in October 2017, data were exported 138 
from The National Referral Database into an Excel Spreadsheet where it went through a process of 139 
data cleaning ready for analysis. The database has been described elsewhere including database 140 
formation, data cleaning, and structure in detail.
22 
The study uses a retrospective cohort longitudinal 141 
study design following individuals entering and exiting ERS following referral from a range of 142 
organisations and referrer types (GPs, nurses, physiotherapists, condition-specific specialists) across 143 
the UK. Due to the inclusion of various schemes within the database, in order to account for scheme 144 
level variance, a multilevel modelling approach was employed involving, an individual patient data 145 
random effects meta-analysis with a two-stage approach was used (see statistical analysis).  146 
 147 
Outcome Measures 148 
 The National Referral Database used the self-reported International Physical Activity 149 
Questionnaire (IPAQ)-short form to measure physical activity levels of participants. This was the PA 150 
questionnaire which was used by exercise providers who uploaded data onto the National Referral 151 
Database throughout the UK, therefore this was used to measure PA within this study. This 152 
questionnaire was used to determine weekly physical activity, in Metabolic Equivalent (MET)-153 
minutes/week (described below), which was the primary outcome measure. Change in MET-154 
minutes/week of self-reported PA pre- and post- scheme, was used to examine the impact ERSs had 155 
on the participant’s physical activity levels. The IPAQ-short form contains seven open-ended items 156 
surrounding the participants’ last seven day recall of PA and sitting behaviours. Items were structured 157 
to provide scoring on walking, moderate-intensity and vigorous-intensity activity, in addition to 158 
sitting. The IPAQ has been designed for observational research and its test-retest reliability indicates 159 
good stability and high reliability (α >.80), along with concurrent validity.23,24 Both continuous and 160 
categorical indicators of PA come from IPAQ. 161 
 162 
Continuous Analysis of IPAQ  163 
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 Due to the non-normal distribution of energy expenditure in participants, it has been 164 
suggested that continuous indicators be presented as median MET-minutes/week.
25 
A MET is the ratio 165 
of the rate of energy expended during an activity to the rate of energy expended at rest.
26 
A MET is a 166 
unit of energy expenditure and by calculating MET-minutes, can be used to track the amount of PA an 167 
individual is doing per week.
25
 168 
 169 
Categorical Analysis of IPAQ 170 
 There are three categorical levels of PA scoring to classify populations through the IPAQ: 171 
‘low’, ‘moderate’ and ‘high’. Criteria set for each of the levels consider each question asked on the 172 
IPAQ form.
23 The ‘high’ category describes high levels of PA participation; either >1500 MET-173 
minutes/week (consisting of vigorous activity on at least three days), or >3000 MET-minutes/week 174 
(consisting of any combination of activities across seven days). This provides a higher threshold of 175 
measures of total PA and is useful to examine population variation. The ‘moderate’ category defines 176 
an individual to be participating in some activity, more than those in the ‘low’ category (600 to 1499 177 
MET-minutes/week). Those in the ‘low’ category do not engage in at least half an hour moderate-178 
intensity physical activity most days (0 to 599 MET-minutes/week). Individuals in the ‘low’ category 179 
do not meet any criteria from the high or moderate categories, and are not participating in any regular 180 
PA. 181 
 182 
Statistical Analyses 183 
Analyses performed were with the intention of reporting broadly; do we observe a meaningful 184 
change in PA levels in individuals who are undergoing ERSs?  185 
Two stage individual patient data meta-analysis was performed on the both the median pre-186 
ERS, and median change scores, (i.e. post- minus pre-ERS scores) for MET-minutes. Analysis was 187 
also performed on the breakdown of vigorous and moderate intensity activity, walking, and sitting 188 
minutes for pre-ERS, as well as change scores. For stage one, both median pre-ERS for MET-189 
minutes/week and mean pre-ERS for activity breakdowns, and median change scores for MET-190 
minutes/week and mean for activity breakdowns, and their standard errors were derived for each 191 
Are ERSs associated with an increase in PA? 
 8 
scheme. The second stage involved performing a random effects meta-analysis using the ‘metafor’ 192 
package in R (version 3.5.0; R Core Development Team, https://www.r-project.org/) across all 193 
schemes to derive a final point estimate and precision of estimate (95% confidence intervals [CI]). A 194 
random effects model was used as our aim was to estimate the PA levels and changes in PA levels for 195 
individuals undergoing any ERS. We assumed that, due to there being considerable uncertainty in the 196 
manner in which each individual ERS scheme was delivered, it was not a reasonable assumption to 197 
treat them all as providing estimates of a fixed or common effect. That is to say, the variation in effect 198 
sizes estimated for each scheme was assumed not due to solely sampling variation. Estimates were 199 
weighted by inverse sampling variance and restricted maximal likelihood estimation was used in all 200 
models. Schemes without sufficient participants (n < 4) were excluded from analysis. Robustness of 201 
main effects were considered through sensitivity analyses by removal of individual schemes and re-202 
analysis of the random effects model. Where significant estimates became non-significant and vice 203 
versa, in addition to where there were considerable changes in the magnitude and/or precision of those 204 
estimates, the results of sensitivity analyses are reported.  205 
An α level of 0.05 was used to determine statistical significance, however results were not 206 
interpreted dichotomously based purely on this, or whether the 95% CI crossed zero. Instead, the 207 
point estimate and its precision were considered in light of the physical activity guidelines and 208 
interpreted with respect to how meaningful the change was. In this sense, progressively greater 209 
increases in MET-minutes/week are required as starting PA levels increase to move into a higher 210 
category. This was based upon the IPAQ ‘low’, ‘moderate’, and ‘high’ categories. For high we 211 
considered the lower threshold of 1500 MET-minutes/week. Categorical IPAQ data was also 212 
examined and the descriptive proportions both pre- and post-ERS considered across schemes in 213 
addition to longitudinal plotting across the entire sample to examine changes between IPAQ 214 
categories.  215 
 216 
Results 217 
A total of 12 schemes were included in the final analysis, which included a total of 5246 218 
participant’s data with an average age of 53±15 years and 68% of whom were female.  219 
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 220 
Categorical IPAQ Classification   221 
 Examination of categorical data revealed that roughly half of participants who began an ERS 222 
were not classified as having ‘low’ levels of PA. There were shifts from pre-ERS to post-ERS in the 223 
proportions of participants in each category with decreases in the proportion of those in the ‘low’ 224 
categories and increases in both ‘moderate’ and ‘high’. Table 1 shows the proportions across schemes. 225 
Tracking of the entire sample visually (figure 1) showed that participants within the ‘low’ categories 226 
tended to shift into the ‘moderate’ and ‘high’ categories. Some participants within the ‘moderate’ 227 
category also shifted into the ‘high’ category. However, a number of participants in the ‘low’ category 228 
remained in this category, some in the ‘moderate’ category dropped into the ‘low’ category, and some 229 
in the ‘high’ category dropped into both the ‘moderate’ and ‘low’ categories. 230 
 231 
Pre-ERS MET-minutes 232 
For pre-ERS MET-minutes/week the estimate from random effects model was 676 MET-233 
minutes/week [539 to 812 minutes], p < .0001). Figure 2 shows the forest plot for pre-ERS MET-234 
minutes. Significant heterogeneity was evident among the schemes (Q(11) = 84.31, p < .0001; I
2
 = 235 
90.41%), however, sensitivity analysis did not reveal any influential schemes.  236 
 237 
Pre-ERS Breakdown of Activity Minutes 238 
Forest plots are shown for pre-ERS breakdown of activity minutes in figure 3. For pre-ERS 239 
vigorous activity the estimate from random effects model was 25 minutes [16 to 34 minutes], p < 240 
.0001). Significant heterogeneity was evident among the schemes (Q(10) = 128.54, p < .0001; I
2
 = 241 
87.52%), however, sensitivity analysis did not reveal any influential schemes. For pre-ERS moderate 242 
activity the estimate from random effects model was 45 minutes [38 to 51 minutes], p < .0001). 243 
Significant heterogeneity was evident among the schemes (Q(11) = 84.15, p < .0001; I
2
 = 87.52%), 244 
however, sensitivity analysis did not reveal any influential schemes. For pre-ERS walking the 245 
estimate from random effects model was 59 minutes [48 to 69 minutes], p < .0001). Significant 246 
heterogeneity was evident among the schemes (Q(11) = 167.73, p < .0001; I
2
 = 96.66%), however, 247 
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sensitivity analysis did not reveal any influential schemes. For pre-ERS sitting the estimate from 248 
random effects model was 384 minutes [352 to 415 minutes], p < .0001). Significant heterogeneity 249 
was evident among the schemes (Q(11) = 365.00, p < .0001; I
2
 = 97.20%), however, sensitivity 250 
analysis did not reveal any influential schemes.  251 
 252 
Change in MET-minutes 253 
For change in MET-minutes/week the estimate from random effects model for was 540 MET-254 
minutes/week [396 to 684 minutes], p < .0001). Figure 4 shows the forest plot for change in MET-255 
minutes. Significant heterogeneity was evident among the schemes (Q(11) = 47.44, p < .0001; I
2
 = 256 
84.90%), however, sensitivity analysis did not reveal any influential schemes. Considering the 257 
estimate for pre-ERS MET-minutes/week (676 MET-minutes) it would seem that the estimate for 258 
change in MET-minutes/week resulted in participants beginning as moderately active and, though 259 
their activity levels increased and categorical analysis showed changes, the effect estimate for change 260 
in activity levels were insufficient to result in a change in IPAQ category with them remaining 261 
moderately active. 262 
 263 
Breakdown of Change Activity Minutes 264 
Forest plots are shown for pre-ERS breakdown of activity minutes in figure 5. For change in 265 
vigorous activity the estimate from random effects model was 17 minutes [9 to 24 minutes], p < 266 
.0001). Significant heterogeneity was evident among the schemes (Q(11) = 480.16, p < .0001; I
2
 = 267 
97.87%), however, sensitivity analysis did not reveal any influential schemes. For change in moderate 268 
activity the estimate from random effects model was 29 minutes [22 to 36 minutes], p < .0001). 269 
Significant heterogeneity was evident among the schemes (Q(11) = 133.55, p < .0001; I
2
 = 92.14%), 270 
however, sensitivity analysis did not reveal any influential schemes. For change in walking the 271 
estimate from random effects model was -5 minutes [-14 to 5 minutes], p = 0.3687). Significant 272 
heterogeneity was evident among the schemes (Q(11) = 94.79, p < .0001; I
2
 = 95.91%), however, 273 
sensitivity analysis did not reveal any influential schemes. For change in sitting the estimate from 274 
random effects model was -61 minutes [-78 to -43 minutes], p < .0001). Significant heterogeneity was 275 
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evident among the schemes (Q(11) = 88.51, p < .0001; I
2
 = 90.63%), however, sensitivity analysis did 276 
not reveal any influential schemes.  277 
 278 
Exploratory Meta-Regression 279 
 Due to the finding that ERS schemes appear to be attracting those who are categorised as 280 
having either ‘moderate’ or ‘high’ PA levels despite guidance suggesting they should be aimed at 281 
those who have ‘low’ PA levels, exploratory analysis was performed using mixed effects meta-282 
regression to examine the relationship between proportion of participants (%) in each scheme 283 
categorised as having ‘low’ PA levels, and changes in PA levels. The coefficient for change in total 284 
MET-minutes was not significant (-5.7 MET-minutes [-17.3 to 5.9], p = 0.3347) with a significant 285 
residual heterogeneity (QE(10) = 39.91, p < 0.0001) and R
2 
= 0.00%. Figure 6 shows the meta-analytic 286 
scatterplot for change in total MET-minutes and proportion of participants categorised as ‘low’ 287 
physical activity. 288 
The coefficient for change in total vigorous minutes was not significant (-0.3 minutes [-0.9 to 289 
0.3], p = 0.3204) with a significant residual heterogeneity (QE(10) = 443.79, p < 0.0001) and R
2 
= 290 
0.00%. The coefficient for change in moderate minutes was not significant (0.2 minutes [-0.3 to 0.7], 291 
p = 0.4684) with a significant residual heterogeneity (QE(10) = 132.00, p < 0.0001) and R
2 
= 0.00%. 292 
The coefficient for change in walking minutes was not significant (0.3 minutes [-0.4 to 1.1], p = 293 
0.3788) with a significant residual heterogeneity (QE(10) = 93.03, p < 0.0001) and R
2 
= 0.00%. The 294 
coefficient for change in sitting minutes was not significant (0.4 minutes [-0.8 to 1.7], p = 0.5230) 295 
with a significant residual heterogeneity (QE(10) = 75.60, p < 0.0001) and R
2 
= 0.00%. Figure 7 shows 296 
the meta-analytic scatterplots for change in breakdown of activity minutes and proportion of 297 
participants categorised as ‘low’ physical activity. 298 
 299 
DISCUSSION  300 
  The aim of the present study was to examine changes in PA in participants who had 301 
completed an ERS. This study utilised data from the UK’s first National Referral Database.22 302 
Categorical data revealed that roughly half of the participants entering the ERSs examined were 303 
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classified as having ‘moderate’ or ‘high’ levels of PA. Effect estimates from meta-analysis showed 304 
that pre-ERS participants total PA fell in the ‘moderate’ category, completing a median 676 MET-305 
minutes/week [539 to 812 minutes], comprising of 25 minutes [16 to 34 minutes] vigorous activity, 306 
45 minutes [38 to 51 minutes] moderate activity, 59 minutes [48 to 69 minutes] walking, and 384 307 
minutes [352 to 415 minutes] sitting. Significant increases of 540 MET-minutes/week [396 to 684 308 
minutes] occurred in participants undergoing ERSs, and this change occurred as a result of increases 309 
in vigorous activity of 17 minutes [9 to 24 minutes], increases in moderate activity of 29 minutes [22 310 
to 36 minutes], and reductions in sitting time of -61 minutes [-78 to -43 minutes]. Little change was 311 
reported in weekly walking minutes (-5 minutes [-14 to 5 minutes]). Overall changes were primarily 312 
facilitated by increased moderate-to-vigorous physical activity (MVPA) and reduced sitting.  Though, 313 
categorical data showed at the group level positive changes in the proportions of participants within 314 
each IPAQ category (i.e. fewer in the ‘low’ and more in the ‘moderate’ and ‘high’ categories), 315 
visualisation of individual data from pre- to post-ERS showed that changes occurred in both 316 
directions with some participants moving to higher, and lower, categories. Consideration of the meta-317 
analytic effect estimate for change would suggest that this was not sufficient to result in categorical 318 
change within the population and participants where on average still classed as ‘moderately active’. 319 
 Research suggests that a dose-response relationship occurs between physical activity and 320 
health benefits if individuals can improve MET-minutes/week by 500-1000 MET/min/week.
26 
Here, 321 
participants change, though statistically significant, barely achieved this threshold, which may explain 322 
the small changes observed in health and wellbeing outcomes in persons undergoing ERSs.
21
 It is also 323 
thought that the dose-response curve for PA is steepest at the lowest end of the curve,
27 
i.e. moving 324 
from a ‘no’ or ‘low’ to a ‘moderate’ PA level. Though, the meta-analytic estimate suggested 325 
participants in this study tended to be already moderately active at the beginning of their ERSs. 326 
Indeed, in previous studies some proportion of participants undergoing ERSs have reported 327 
themselves as being ‘moderately inactive’ (15.3% 19). Chalder et al 18 also reported that ~25-28% of 328 
their participants were already achieving at least 1000 MET-minutes/week of PA at baseline. This is 329 
perhaps a cause for concern as the NICE guidelines 
13,16
 suggest ERSs should be targeted towards 330 
inactive individuals. The observational data presented here would suggest that this recommendation is 331 
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not being followed.  However, it should be considered that some participants may be overestimating 332 
their levels of PA, and not accurately recording their activity.  333 
A number of participants moved from the ‘low’ category to both the ‘moderate’ and ‘high’ 334 
categories and, considering the dose-response nature of PA changes, it may be that the more 335 
meaningful PA, health  and wellness changes primarily occur in those who begin an ERS categorised 336 
as inactive. However, exploratory meta-regression analysis examining whether there was an 337 
association between the proportion of participants in schemes classified as having ‘low’ PA levels did 338 
not demonstrate this. Further, supplementary analysis performed by Wade et al.
21
 did not show 339 
particularly strong relationships between changes in PA levels and health and wellbeing outcomes in 340 
ERS participants from analysis conducted using The National Referral Database.  341 
 ERS can and do increase PA levels, however the value of this to a participant’s health 342 
outcomes is less clear. In their systematic review and meta-analysis, Pavey, et al.
 1
 reported that, 343 
compared with usual care, ERSs have a slightly greater impact on the number of participants 344 
achieving between 90-150 minutes of moderate activity per week. However, they noted that at the 345 
time evidence was weak. Using seven-day PA recall, Murphy, et al. 
19 
found that ERS group 346 
participants at 12 months’ post intervention achieved a median of 200 minutes of exercise compared 347 
with 165 for the control group. Chalder, et al. 
18
 found increases post intervention, though no 348 
significant differences, in proportion of participants meeting at least 1000 MET-minutes/week 349 
between ERS or usual care in depressed adults, though descriptively they noted slight differences 350 
(ERS = 52% at four months, 63% at eight months, and 58% at twelve months; Usual care = 43% at 351 
four months, 49% at eight months, and 40% at twelve months). Our results show changes likely do 352 
occur, although not of considerable magnitude.  353 
 It is also worth considering the nature of the change in PA levels. The increases in total PA 354 
where primarily driven by increases in MVPA and decreased sitting. Participants increased MVPA 355 
per week by ~46 minutes (17 minutes vigorous and 29 minutes’ moderate), yet walking did not 356 
change much in participants undergoing ERSs. Therefore, it could be recommended that schemes 357 
should encourage walking outside of an ERS attendance, as there was no change reported in walking 358 
post-completion. Though walking and light activities are associated with improvements in all-cause 359 
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mortality, these seem to be greatest again at the lower end of the dose-response curve 
28
 and, at an 360 
equal volume, MVPA is associated with greater benefits.
29 
It could therefore be viewed as positive 361 
that MVPA increased in patients undergoing ERSs. Increases in MVPA even in small amounts have 362 
been shown to be associated with reductions in all-cause mortality.
30 
Jefferis, et al. 
30
 reported each 363 
10-minute increase in MVPA per day resulted in a 10% reduction in all-cause mortality risk. 364 
O’Donovan, et al. 31 have recently reported that inclusion of vigorous activity has an even stronger 365 
impact upon cardiovascular disease mortality risk, and participants in this present study showed 366 
increases in vigorous activity, which may still yield significant health benefits beyond the scope of 367 
our timeframe. Further, there was ~1-hour reduction in sitting time per week across participants. 368 
However, recent data shows that reducing sitting time point estimates of ~30 minutes per day are be 369 
considered clinically meaningful.
32
 370 
There are several limitations with the current database 
22
 that are worthy of note and these 371 
partially extend to the data analysis here. Length of scheme is a factor that could influence changes in 372 
PA. However, in this study only schemes of 12 weeks in length were included. In a recent systematic 373 
review,
33 
it was reported that longer length schemes (20+ weeks) improved adherence to PA 374 
prescribed over the course of the scheme. This research emphasises the importance of increasing 375 
length of schemes. Indeed, it may be that if longer schemes where present in the database for analysis 376 
these may reveal greater PA increases compared with shorter schemes. Although other research by 377 
Webb, et al. 
20
 suggests shorter schemes can be effective as it was found that after completing an 8-378 
week ERS, categorical IPAQ scores significantly increased. 379 
 Another limitation, considering PA levels specifically, use of self-reported outcomes, is a 380 
potential issue. IPAQ is of course a subjective measure and was not designed for examination of 381 
change in physical activity levels and this could mean it does not well reflect participants’ objective 382 
changes in physical activity,
24,34
 however, this was the only measure used within the database 383 
reviewing PA levels of participants. Although, a recent study has suggested that participants’ 384 
perceptions of their PA levels relative to others, even when independent of the actual PA conducted 385 
(whether self-reported or device measured), are strong predictors of all-cause mortality.
35 
Although 386 
this study reviewed the effects of ERSs on change in PA, it does not consider the reasons why 387 
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participants chose to attend an ERS. Indeed, many factors influence uptake 
36
 and it seems likely 388 
would influence engagement throughout also. Some participants may have attended due to their own 389 
motivation to improve their health conditions, whereas, other participants may have only attended 390 
because their GP advised them to. A future study could review the reasoning behind individuals’ 391 
uptake in schemes, along with recorded adherence to PA or self-report PA through IPAQ. This could 392 
also be captured by schemes within the database as it is developed. Lastly, similarly to the health and 393 
wellbeing outcomes, there was considerable heterogeneity across schemes with respect to the changes 394 
observed.  395 
 396 
Conclusion  397 
 These results represent the initial findings from first analysis of the National Referral 398 
Database considering PA levels. The analyses performed here were with the intention of considering 399 
broadly “do we observe a change in physical activity in individuals who are undergoing ERSs?” and 400 
the findings suggest that significant changes in total MET-minutes/week do occur. Participants in the 401 
ERSs assessed here were however predominantly ‘moderately active’ at baseline and remained so 402 
post-ERS. Thus, it is not clear the degree to which the changes observed are meaningful or not. 403 
Considering the heterogeneity of results across schemes also, future work, including that afforded by 404 
this database, should be focused upon determining where best practice exists (i.e. what works best for 405 
which population). 406 
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Figure titles 542 
Figure 1. Pre- and post-ERS changes in categorical IPAQ classification across participants. 543 
Figure 2. Forest plot of pre-ERS MET-minutes/week across schemes . 544 
Figure 3. Forest plot of pre-ERS (A) vigorous, (B) moderate, (C) walking, and (D) sitting minutes 545 
across schemes. 546 
Figure 4. Forest plot of change in MET-minutes/week across schemes. 547 
Figure 5. Forest plot of change in (A) vigorous, (B) moderate, (C) walking, and (D) sitting minutes 548 
across schemes. 549 
Figure 6. Meta-analytic scatterplot for change in total MET-minutes and proportion of participants 550 
(%) categorised as ‘low’ physical activity. 551 
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Figure 7. Meta-analytic scatterplots for change in (A) vigorous, (B) moderate, (C) walking, and (D) 552 
sitting minutes and proportion of participants categorised as ‘low’ physical activity 553 
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